BioIntel
AMA Calls for Permanent Medicare Telehealth Services Amid Ongoing Policy Uncertainty
Regulatory & Policy

AMA Calls for Permanent Medicare Telehealth Services Amid Ongoing Policy Uncertainty

BioIntel Editorial TeamBioIntel Editorial TeamJan 6, 20263 min

Despite repeated extensions of telehealth prescribing flexibilities by the DEA and other agencies, uncertainty remains. The AMA advocates for permanent legislative action to ensure stable patient access and provider reimbursement for telehealth services.

Advocacy for Stable Telehealth Policy

  • The AMA called on Congress to permanently extend telehealth flexibilities for Medicare established during the COVID-19 pandemic.
  • Temporary policy extensions create instability for both patients and healthcare providers.
  • Congressional action is seen as crucial for integrating telehealth as a sustainable care model.

Ongoing Telehealth Policy Landscape

  • Regulatory bodies like the DEA have issued multiple short-term extensions for virtual prescribing amid continued debate.
  • Policy permanency is considered essential to foster innovation, access, and care consistency.

Source: MedCity News

Join the BioIntel newsletter

Get curated biotech intelligence across AI, industry, innovation, investment, medtech, and policy—delivered to your inbox.